MENU
NGENF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
NervGen Pharma (NGENF) Ownership - Who owns NervGen Pharma?
Profile
Industry
N/A
Address
112-970 Burrard Street
Phone
+1 778 731-1711
Employees
N/A
Web
https://www.nervgen.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
130.88M
P/E Ratio
N/A
Total Cash
21.01M
Projected Growth
N/A
Total Debt
129.02K
Revenue
N/A
Risk (Beta)
0.93
Dividend Yield
N/A
Total Cash/Share
0.30
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
NGENF
Capitalization
131M
P/E Ratio
N/A
Risk (Beta)
0.93
Dividend Yield
N/A
Total Cash
21M
Total Cash/Share
0.30
Total Debt
129K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
9.18M
P/B Ratio
20.28
Cash Flow
N/A
Earnings
-0.38
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
80.5M
Current Ratio
1.66
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-27.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-123.68
Shares Held By Institutions
0
Shares Outstanding - Current
70.3M
Total Liabilities
13.3M
Total Volume MTD
N/A
Value
-1
Gain YTD
-8.824
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
112-970 Burrard Street
Phone
+1 778 731-1711
Employees
N/A
Web
https://www.nervgen.com